BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31502161)

  • 1. The Adaptome as Biomarker for Assessing Cancer Immunity and Immunotherapy.
    Han J; Lotze MT
    Methods Mol Biol; 2020; 2055():369-397. PubMed ID: 31502161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune repertoire: A potential biomarker and therapeutic for hepatocellular carcinoma.
    Han Y; Li H; Guan Y; Huang J
    Cancer Lett; 2016 Sep; 379(2):206-12. PubMed ID: 26188280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-throughput sequencing of the immune repertoire in oncology: Applications for clinical diagnosis, monitoring, and immunotherapies.
    Ye B; Smerin D; Gao Q; Kang C; Xiong X
    Cancer Lett; 2018 Mar; 416():42-56. PubMed ID: 29247824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T and B Cell Receptor Immune Repertoire Analysis using Next-generation Sequencing.
    Werner L; Dor C; Salamon N; Nagar M; Shouval DS
    J Vis Exp; 2021 Jan; (167):. PubMed ID: 33522509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiling the TRB and IGH repertoire of patients with H5N6 Avian Influenza Virus Infection by high-throughput sequencing.
    Peng W; Liu S; Meng J; Huang J; Huang J; Tang D; Dai Y
    Sci Rep; 2019 May; 9(1):7429. PubMed ID: 31092835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of the T cell receptor repertoire.
    Uddin I; Woolston A; Peacock T; Joshi K; Ismail M; Ronel T; Husovsky C; Chain B
    Methods Enzymol; 2019; 629():465-492. PubMed ID: 31727254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in T and B Cell Receptor Repertoires Patterns in Patients With IL10 Signaling Defects and History of Infantile-Onset IBD.
    Werner L; Lee YN; Rechavi E; Lev A; Yerushalmi B; Ling G; Shah N; Uhlig HH; Weiss B; Somech R; Snapper SB; Shouval DS
    Front Immunol; 2020; 11():109. PubMed ID: 32117262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell receptor repertoire usage in cancer as a surrogate marker for immune responses.
    Schrama D; Ritter C; Becker JC
    Semin Immunopathol; 2017 Apr; 39(3):255-268. PubMed ID: 28074285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3D: diversity, dynamics, differential testing - a proposed pipeline for analysis of next-generation sequencing T cell repertoire data.
    Zhang L; Cham J; Paciorek A; Trager J; Sheikh N; Fong L
    BMC Bioinformatics; 2017 Feb; 18(1):129. PubMed ID: 28241742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next generation sequencing reveals novel alterations in B-cell heavy chain receptor repertoires associated with acute-on-chronic liver failure.
    Yan Q; Wang L; Lai L; Liu S; Chen H; Zhang J; Dai Y; Sui W
    Int J Mol Med; 2019 Jan; 43(1):243-255. PubMed ID: 30365073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal distribution and intratumour heterogeneity of the B-cell repertoire in oesophageal squamous cell carcinoma.
    Zhang C; Huang H; Miao Y; Xiong H; Lu Z
    J Pathol; 2018 Nov; 246(3):323-330. PubMed ID: 30027584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing human B cell repertoire diversity and convergence.
    Imkeller K; Wardemann H
    Immunol Rev; 2018 Jul; 284(1):51-66. PubMed ID: 29944762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Describing the diversity of Ag specific receptors in vertebrates: Contribution of repertoire deep sequencing.
    Castro R; Navelsaker S; Krasnov A; Du Pasquier L; Boudinot P
    Dev Comp Immunol; 2017 Oct; 75():28-37. PubMed ID: 28259700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of immune repertoire sequencing in cancer immunotherapy.
    Zhuang Y; Zhang C; Wu Q; Zhang J; Ye Z; Qian Q
    Int Immunopharmacol; 2019 Sep; 74():105688. PubMed ID: 31276974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell receptor repertoire analysis for the diagnosis and treatment of solid tumor: A methodology and clinical applications.
    Li N; Yuan J; Tian W; Meng L; Liu Y
    Cancer Commun (Lond); 2020 Oct; 40(10):473-483. PubMed ID: 32677768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TCR Repertoire as a Novel Indicator for Immune Monitoring and Prognosis Assessment of Patients With Cervical Cancer.
    Cui JH; Lin KR; Yuan SH; Jin YB; Chen XP; Su XK; Jiang J; Pan YM; Mao SL; Mao XF; Luo W
    Front Immunol; 2018; 9():2729. PubMed ID: 30524447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Method for identification of condition-associated public antigen receptor sequences.
    Pogorelyy MV; Minervina AA; Chudakov DM; Mamedov IZ; Lebedev YB; Mora T; Walczak AM
    Elife; 2018 Mar; 7():. PubMed ID: 29533178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next-generation sequencing analysis of the human T-cell and B-cell receptor repertoire diversity before and after hepatitis B vaccination.
    Miyasaka A; Yoshida Y; Wang T; Takikawa Y
    Hum Vaccin Immunother; 2019; 15(11):2738-2753. PubMed ID: 30945971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status and recent advances of next generation sequencing techniques in immunological repertoire.
    Hou XL; Wang L; Ding YL; Xie Q; Diao HY
    Genes Immun; 2016 Apr; 17(3):153-64. PubMed ID: 26963138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptive Immunity and the Tumor Microenvironment.
    Han ; Lotze
    Cancer Treat Res; 2020; 180():111-147. PubMed ID: 32215868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.